Beryl Drugs Ltd

NSE: BERLDRG · BSE: 524606 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹25.55
Market cap: ₹12.96 Cr
Revenue (annual): ₹18.82 Cr
Net profit (annual): ₹0.42 Cr
P/E (TTM): 20.8×Sector 47.3×
Promoter holding: 27.82%+0.34% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Outcome 4 Board Meeting Date 4 Annual General Meeting 4 Promoter Buying 3 Other Announcement 3 Financial Results 3 Debt & Borrowing 1 Capacity Expansion 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

8 Apr 2026 15:32 IST BSE

Debt & Borrowing

Beryl Drugs Debt & Borrowing: ₹2.39 Cr

Beryl Drugs Ltd (BSE: 524606) has submitted its initial disclosure confirming it is not identified as a Large Corporate as of March 31, 2026. The company reported outstanding borrowings of ₹2.39 Crore, falling below the SEBI threshold for large corporate classification.

Value: ₹2.39 Cr

Read the filing ↗